A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.

Nature Communications
Perrine SoretJacques-Olivier Pers

Abstract

There is currently no approved treatment for primary Sjögren's syndrome, a disease that primarily affects adult women. The difficulty in developing effective therapies is -in part- because of the heterogeneity in the clinical manifestation and pathophysiology of the disease. Finding common molecular signatures among patient subgroups could improve our understanding of disease etiology, and facilitate the development of targeted therapeutics. Here, we report, in a cross-sectional cohort, a molecular classification scheme for Sjögren's syndrome patients based on the multi-omic profiling of whole blood samples from a European cohort of over 300 patients, and a similar number of age and gender-matched healthy volunteers. Using transcriptomic, genomic, epigenetic, cytokine expression and flow cytometry data, combined with clinical parameters, we identify four groups of patients with distinct patterns of immune dysregulation. The biomarkers we identify can be used by machine learning classifiers to sort future patients into subgroups, allowing the re-evaluation of response to treatments in clinical trials.

References

Mar 19, 2003·The Journal of Experimental Medicine·Lynda BennettVirginia Pascual
Dec 14, 2004·Arthritis and Rheumatism·Kyriakos A KirouMary K Crow
Dec 31, 2005·Arthritis and Rheumatism·Frédérique d'ArbonneauPierre Youinou
Nov 2, 2006·Briefings in Bioinformatics·David L GoldBani Mallick
May 16, 2008·Biometrical Journal. Biometrische Zeitschrift·Torsten HothornPeter Westfall
Jun 27, 2008·European Journal of Immunology·Manon E WildenbergMarjan A Versnel
Nov 1, 2008·Bioinformatics·Andrew D JohnsonPaul I W de Bakker
Mar 9, 2010·Nature Methods·Shai S Shen-OrrAtul J Butte
Oct 29, 2010·Genome Biology·Simon Anders, Wolfgang Huber
Nov 3, 2010·Immunology·Nicolas SchleinitzEric Vivier
Jul 26, 2011·Oncogene·M GuedjC Theillet
Jul 18, 2012·Nature Reviews. Rheumatology·Daniel J WallaceSwamy R Venuturupalli
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Dec 4, 2012·Nucleic Acids Research·Andrea FranceschiniLars J Jensen
Dec 18, 2013·Bioinformatics·Tiffany J MorrisStephan Beck
Dec 19, 2013·Annals of the Rheumatic Diseases·Xavier MarietteSalvatore De Vita
Mar 7, 2014·Genes and Immunity·D L MorrisL A Criswell
Apr 15, 2014·Annals of Internal Medicine·Valérie Devauchelle-PensecAlain Saraux
Jun 19, 2014·Annals of the Rheumatic Diseases·Baodong QinRenqian Zhong
Jul 17, 2014·JAMA : the Journal of the American Medical Association·Jacques-Eric GottenbergXavier Mariette
Jan 22, 2015·Nucleic Acids Research·Matthew E RitchieGordon K Smyth
Sep 12, 2015·Scientific Reports·Ratnadeep MukherjeeBalachandran Ravindran
Mar 13, 2016·Autoimmunity Reviews·Andreas V Goules, Athanasios G Tzioufas
Jul 8, 2016·Nature Reviews. Disease Primers·Pilar Brito-ZerónManuel Ramos-Casals
Oct 25, 2016·Autoimmunity Reviews·Christophe JaminJacques-Olivier Pers
Mar 3, 2017·BMC Bioinformatics·Antonio FabregatHenning Hermjakob
Feb 22, 2018·Nature Reviews. Rheumatology·Guillermo BarturenMarta E Alarcón-Riquelme
Jul 10, 2019·Expert Opinion on Emerging Drugs·Saviana Gandolfo, Salvatore De Vita

❮ Previous
Next ❯

Citations

Jul 7, 2021·Nature Reviews. Rheumatology·Joanna Clarke
Nov 30, 2021·Expert Review of Clinical Immunology·Emiko DesvauxPhilippe Moingeon

❮ Previous
Next ❯

Software Mentioned

Reactome
STAR
Plink
ChAMP
scikit
hat
limma
minfi
numpy
Minimac3

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Arthritis & Rheumatology
Alan N Baer, Katherine M Hammitt
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
K Taneichi, H Shibaki
The New England Journal of Medicine
Xavier Mariette, Lindsey A Criswell
The New England Journal of Medicine
Xavier Mariette, Lindsey A Criswell
Annals of Internal Medicine
N A VANSELOWI F DUFF
© 2021 Meta ULC. All rights reserved